As Mike Schuster nears the three-year anniversary of his diagnosis with glioblastoma, he’s already doubled the life expectancy for patients with the deadly cancer.
Agreement will expand clinical trials of glioblastoma drug
Technology Ventures works to pair scientists with industry partners.
OMRF’s biomarker discoveries could bring new therapies for beating gliomas.
OMRF, Stephenson Cancer Center begin tests of experimental compound
Cutting off avenues for growth is key to killing tumors.